All News

15/04 Baird Adjusts Price Target on ResMed to $254 From $272, Maintains Neutral Rating MT
13/04 Mizuho Adjusts Price Target on ResMed to $255 From $300, Maintains Outperform Rating MT
09/04 Resmed Insider Sold Shares Worth $1,125,486, According to a Recent SEC Filing MT
08/04 Citigroup Adjusts Price Target on ResMed to $340 From $345, Maintains Buy Rating MT
02/04 Resmed Insider Sold Shares Worth $450,000, According to a Recent SEC Filing MT
02/04 Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026 GL
11/03 Resmed Insider Sold Shares Worth $1,252,902, According to a Recent SEC Filing MT
11/03 Baird Adjusts Price Target on ResMed to $272 From $281, Maintains Neutral Rating MT
06/03 Resmed Insider Sold Shares Worth $520,440, According to a Recent SEC Filing MT
04/03 Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains out of Reach AQ
04/03 ASX Biggest Gainers MT
03/03 Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach GL
27/02 SomnoMed Limited Announces Management Appointments CI
25/02 Shares of Resmed Fall 3% After Declaring Plan to Open New US Distribution Center MT
24/02 Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana CI
24/02 ResMed to Open New Distribution Center in Indiana MT
24/02 ResMed expands US operations with new distribution center in Indiana RE
24/02 Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana GL
12/02 FA
11/02 Resmed : Introduces Full Face Fabric Mask Designed for Comfort and Improved Sleep Health in the US PU
11/02 Resmed Insider Sold Shares Worth $1,366,436, According to a Recent SEC Filing MT
06/02 Resmed Insider Sold Shares Worth $502,620, According to a Recent SEC Filing MT
06/02 ResMed Chief Legal Officer Sells 50 Common Shares Of Firm MT
06/02 ResMed Director Sells 2,000 Shares MT
06/02 ASX Biggest Gainers MT
No results for this search